Combined Therapeutics Patents – Insights & Stats (Updated 2024)

Combined Therapeutics has a total of 48 patents globally, out of which 7 have been granted. Of these 48 patents, more than 83% patents are active. Europe (EPO) is where Combined Therapeutics has filed the maximum number of patents, followed by USA and Japan. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Combined Therapeutics.

Combined Therapeutics was founded in 2016. Combined Therapeutics is a pioneering biotech focused on advancing immunotherapy for cancer treatment at the pre-clinical stage, aiming to revolutionize cancer care.

Do read about some of the most popular patents of Combined Therapeutics which have been covered by us in this article and also you can find Combined Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Combined Therapeutics patent portfolio.

How many patents does Combined Therapeutics have?

Combined Therapeutics has a total of 48 patents globally. These patents belong to 2 unique patent families. Out of 48 patents, 40 patents are active.

How Many Patents did Combined Therapeutics File Every Year?

Combined Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCombined Therapeutics Applications FiledCombined Therapeutics Patents Granted
202356
202251
202116
20204
20197
201811

How many Combined Therapeutics patents are Alive/Dead?

Worldwide Patents

Combined Therapeutics Patent Portfolio

How Many Patents did Combined Therapeutics File in Different Countries?

Combined Therapeutics Worldwide Patent Filing

Countries in which Combined Therapeutics Filed Patents

CountryPatent
Europe6
United States Of America5
Japan5
Canada4
Australia4
Mexico4
Singapore2
Hong Kong (S.A.R.)2
South Africa2
India2
Israel2
Brazil1
Poland1
Spain1
Portugal1
Austria1
Italy1

Where are Research Centers of Combined Therapeutics Patents Located?

R&D Centres of Combined Therapeutics

What Percentage of Combined Therapeutics US Patent Applications Were Granted?

Combined Therapeutics (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100%.

Below are the key stats of Combined Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Combined Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Dla Piper Llp Us2100%

List of Combined Therapeutics patents

Combined Therapeutics PatentsTitle
US11596685B2Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
US11359212B2Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue
US20230241206A1Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
US20220220506A1Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue
US20200376142A1Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
EP3678673B1Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue
EP4218770A3Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue
EP4188393A1Compositions And Methods For Improved Vaccination
EP4106770A1Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
EP4008333A1Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
EP3755344A1Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
PL3678673T3Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue
ES2942890T3Compositions And Methods For Targeted Delivery, Expression And Modulation Of Encoding Ribonucleic Acids In Tissues
IT202300019191T2Compositions And Procedures For The Administration, Expression And Targeted Modulation Of Ribonucleic Acids Coding In The Tissue.
PT3678673TCompositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue
JP2023536844ACompositions And Methods For Improving Vaccination
JP2023514594ACompositions And Methods For Organ-Protective Expression And Regulation Of Encoded Ribonucleic Acids
MX2023001187ACompositions And Methods For Improved Vaccination
AU2021326420A1Compositions And Methods For Improved Vaccination
MX2022010084ACompositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids.
AU2021224990A1Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
CA3187345A1Compositions And Methods For Improved Vaccination
CA3168048A1Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
MX2020008606ACompositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids.
MX2020002568ACompositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue.
AU2019221826A1Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
AU2018328289A1Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue
CA3091543A1Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
CA3074293A1Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue
ZA202208795BCompositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
IN202327005521ACompositions And Methods For Improved Vaccination
HK40022397A1Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue
IL300247ACompositions And Methods For Improved Vaccination
SG11202300677UACompositions And Methods For Improved Vaccination
ZA202301219ACompositions And Methods For Improved Vaccination
IN202227052816ACompositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
IL295724ACompositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
SG11202251944HACompositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
HK40035129ACompositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
BR112023001563A2Compositions And Methods For Improved Vaccination
AT1545499TZusammensetzungen Und Verfahren Zur Gezielten Abgabe, Expression Und Modulation Codierender Ribonukleinsäuren In Gewebe
WO2022035621A1Compositions And Methods For Improved Vaccination
WO2021168405A1Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
WO2019158955A9Compositions And Methods For Organ-Protective Expression And Modulation Of Coding Ribonucleic Acids
WO2019051100A1Compositions And Processes For Targeted Delivery, Expression And Modulation Of Coding Ribonucleic Acids In Tissue
JP2023159160ACompositions And Processes For Targeted Delivery, Expression And Regulation Of Encoded Ribonucleic Acids In Tissues
JPWO2019158955A5Compositions And Methods For Organ-Protective Expression And Regulation Of Encoded Ribonucleic Acids
JP2020533411A5Compositions And Processes For Targeted Delivery, Expression And Regulation Of Encoded Ribonucleic Acids In Tissues

What are Combined Therapeutics key innovation segments?

What Technologies are Covered by Combined Therapeutics?

The chart below distributes patents filed by Combined Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Combined Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Combined Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Combined Therapeutics?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.